QIAGEN powered by

Webinars and events

Loading Events

« All Events

Translating COSMIC’s gold standard data into actionable insights

December 7, 2023 @ 11:00 am - 12:00 pm

As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, researchers, scientists, and clinicians need an accessible, streamlined and standardized way of keeping track of this potentially crucial, ever-growing body of actionable knowledge. Over the course of 20 years, COSMIC, the Catalogue Of Somatic Mutations In Cancer, has expertly curated the world’s largest, most comprehensive database for somatic mutation information relating to human cancer. Today, COSMIC is used worldwide by revered research and clinical institutes, biotech and pharmaceutical companies, and more.
In this webinar, Leonie Hodges, Scientific Communications Officer for COSMIC, will delve into the wide range of datasets that COSMIC offers, detailing the content, how to obtain actionable insights from the genomic data, and how to potentially use this data for real-world applications. Following the talk, there will be a live Q&A with Jennifer Wilding, Scientist Curator at COSMIC and Alex Holmes, Senior Database Curator at COSMIC.
By attending this webinar, you will learn how to:
  • Explore the wide range of datasets that COSMIC offers, including the Cancer Mutation Census and Mutational Signatures;
  • Gain insights from COSMIC’s gold standard genomic data by taking either a disease or gene centric view of your research;
  • Identify potential applications of COSMIC data and how it enables users from a plethora of disciplines to experiment and innovate with confidence.


Date: December 7, 2023
 11:00 am - 12:00 pm
Register for event
Event Categories:
Event Tags:


Virtual – Americas – EST
United States


Clinical, Webinar
Register for event

On-demand Webinars

  • Supercharge your AI in drug discovery with high-quality biomedical data

    If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn’t enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying data must be of ‘hig...

  • Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS Batch for execution. ...

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle appli...

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic vari...

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled man...

  • What’s new in QIAGEN IPA Fall Release 2023?

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to pathways ...